Sponsor
Harpoon Therapeutics Inc.
611 Gateway Boulevard Suite 400, 94080-7066, United States
About the sponsor
Research activity is centered on multiple myeloma, with attention to relapsed and refractory disease in patients whose cancer has returned or no longer responds to treatment.
- Relapsed/Refractory Multiple Myeloma
- Recurrent Multiple Myeloma
The sponsor’s clinical program is focused on difficult-to-treat plasma cell disorders in the oncology setting.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.